Ignite Creation Date:
2024-05-06 @ 8:09 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06279663
Status:
RECRUITING
Last Update Posted:
2024-03-13
First Post:
2024-02-15
Brief Title:
Management Tactics for Patients High Risk With Acute Coronary Syndrome Without ST Segment Elevation and Multivessel Coronary Artery Disease
Sponsor:
Federal State Budgetary Institution National Medical Research Center named after academician EN Me
Organization:
Federal State Budgetary Institution National Medical Research Center named after academician EN Me
Study Overview
Official Title:
A Prospective Multicenter Randomized Trial Management Tactics for Patients High Risk With Acute Coronary Syndrome Without ST Segment Elevation and Multivessel Coronary Artery Disease
Status:
RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
NSTE-ACSMT
Brief Summary:
The study will include patients with acute coronary syndrome without ST segment elevation and multivessel CA lesion who are subject to surgical treatment according to KG data Syntax Score 23 - 32 points with significant damage to the anterior descending artery andor trunk of the left coronary artery The patient should be suitable for both CABG and PCI confirmed by an X-ray surgeon and a cardiac surgeon An X-ray surgeon and a cardiac surgeon within the framework of planning the volume of revascularization strives for the fullest feasible volume Complete myocardial revascularization that is the desire for the absence of hemodynamically significant coronary arteries after revascularization with a diameter of 25 mm that is residual coronary artery stenosis of no more than 60 Thus patients will be randomized into groups in a ratio of 11 Each group will need to include 230 patients a total of 460 In the main group revascularization will be performed by PCI in the control group by CABG
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None